
Mohbad Paternity Case Stalled as UK Labs Reject Embalmed Body DNA Analysis
The ongoing paternity dispute involving late Nigerian singer Mohbad has encountered a significant setback, as two United Kingdom-approved laboratories have reportedly declined to conduct DNA analysis on his embalmed body.
The development has raised fresh concerns about the possibility of resolving the highly publicized case, which has drawn widespread attention across Nigeria and beyond. The paternity issue, centered on establishing the biological relationship between Mohbad and a child claimed to be his, has been a focal point of legal and public debate since the singer’s death in 2023.
According to reports, the laboratories rejected the request due to the condition of the body, which had been embalmed following Mohbad’s burial. Experts indicate that embalming chemicals can degrade or contaminate DNA, making it difficult to obtain accurate and reliable genetic material for testing. As a result, the labs reportedly concluded that proceeding with the analysis could compromise the integrity of the results.
This development poses a major challenge for all parties involved, as DNA testing is widely regarded as the most definitive method for establishing paternity. Without access to viable biological samples from the deceased, legal proceedings surrounding the case may face further delays or complications.
The paternity dispute has been closely linked to broader controversies surrounding Mohbad’s death. Following his passing, public outcry led to calls for thorough investigations into the circumstances of his death, as well as related issues involving his personal and professional life. Authorities later exhumed his body as part of ongoing investigations, with forensic analysis expected to shed light on multiple aspects of the case.
However, the rejection by the UK-based labs highlights the technical limitations that can arise in post-mortem examinations, particularly when preservation methods such as embalming have been used. Forensic specialists note that while DNA can sometimes still be extracted from embalmed remains, success rates vary significantly depending on factors such as the duration of preservation and the chemicals used.
Legal analysts suggest that alternative approaches may now need to be considered. These could include obtaining DNA samples from close biological relatives of the deceased, which can sometimes be used to establish paternity through indirect comparison. However, such methods may also involve legal and procedural complexities, particularly if consent or cooperation becomes an issue.
The case continues to attract intense public interest, with many Nigerians following developments closely on social media and in the news. Supporters of the late singer have expressed frustration over the delays, calling for authorities to explore all possible avenues to ensure that the truth is established.
Family members and legal representatives involved in the dispute have yet to issue comprehensive statements regarding the next steps. However, sources indicate that consultations are ongoing to determine the most viable path forward in light of the latest setback.
Beyond the immediate paternity issue, the case underscores the broader challenges associated with forensic investigations in high-profile cases. It also raises questions about the handling of remains in situations where future legal or scientific examinations may be required.
As the situation unfolds, stakeholders are expected to weigh their options carefully, balancing scientific feasibility with legal requirements. The outcome of the case could have lasting implications not only for those directly involved but also for how similar cases are approached in the future.
For now, the Mohbad paternity case remains unresolved, with the rejection by UK-approved laboratories marking a critical turning point in the pursuit of answers. Observers hope that despite the obstacles, a solution can still be found to bring clarity and closure to a matter that continues to capture national attention.